{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Department of Pharmacy, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong Province, China",
    "Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong Province, China",
    "Pharmacy Department, Shantou University Medical College, Shantou, Guangdong Province, China"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Zhiwei Zheng"
    },
    {
      "affs": [
        1
      ],
      "name": "Lisheng Huang"
    },
    {
      "affs": [
        2
      ],
      "name": "Yuling Zhang"
    },
    {
      "affs": [
        0
      ],
      "name": "Huide Zhu"
    },
    {
      "affs": [
        0
      ],
      "name": "Ling Fang"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7vyezcrjy1be6.bib",
  "cited_by": 0,
  "doi": "10.1080/1750743x.2026.2743426",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13699833/",
  "id": "7vyezcrjy1be6",
  "issns": [
    "1750-743X",
    "1750-7448"
  ],
  "landing_url": "https://doi.org/10.1080/1750743x.2026.2743426",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "2002|Health Systems, Economic Evaluations, Quality of Life"
    ]
  ],
  "openalex": "W7220410825",
  "pdf_url": null,
  "pmcid": "PMC13699833",
  "pmid": "42830582",
  "published": "2026-10-04",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/7vyezcrjy1be6.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:20:23Z",
      "native_id": "PMC13699833",
      "source": "pmc",
      "url": "https://doi.org/10.1080/1750743x.2026.2743426"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "journal-openalex:F27",
      "subfield": "general"
    }
  ],
  "title": "Cost-effectiveness analysis of penpulimab plus anlotinib versus sorafenib as first-line therapy for advanced hepatocellular carcinoma",
  "title_text": "Cost-effectiveness analysis of penpulimab plus anlotinib versus sorafenib as first-line therapy for advanced hepatocellular carcinoma",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:36:21Z",
  "url": "https://research.draconitic.com/paper/7vyezcrjy1be6",
  "venue": "Immunotherapy",
  "versions": []
}